Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Harvard Business School
Farmers Insurance
QuintilesIMS
Colorcon
Accenture
Baxter
Deloitte
Boehringer Ingelheim
US Department of Justice

Generated: January 20, 2018

DrugPatentWatch Database Preview

CHLOROTHIAZIDE Drug Profile

« Back to Dashboard

When do Chlorothiazide patents expire, and when can generic versions of Chlorothiazide launch?

Chlorothiazide is a drug marketed by Abc Holding, Hikma Intl Pharms, Lederle, Mylan, Sandoz, Watson Labs, Hikma Pharms, Fresenius Kabi Usa, Luitpold, Mylan Institutional, Sagent Pharms, and Sun Pharma Global. and is included in twenty-three NDAs.

The generic ingredient in CHLOROTHIAZIDE is chlorothiazide sodium. There are forty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the chlorothiazide sodium profile page.
Drug patent expirations by year for CHLOROTHIAZIDE
Pharmacology for CHLOROTHIAZIDE
Ingredient-typeThiazides
Drug ClassThiazide Diuretic
Physiological EffectIncreased Diuresis

US Patents and Regulatory Information for CHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abc Holding CHLOROTHIAZIDE chlorothiazide TABLET;ORAL 085569-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Institutional CHLOROTHIAZIDE SODIUM chlorothiazide sodium INJECTABLE;INJECTION 202493-001 Jun 18, 2014 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan CHLOROTHIAZIDE-RESERPINE chlorothiazide; reserpine TABLET;ORAL 087745-001 May 6, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan CHLOROTHIAZIDE chlorothiazide TABLET;ORAL 084217-001 Approved Prior to Jan 1, 1982 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lederle CHLOROTHIAZIDE chlorothiazide TABLET;ORAL 086940-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs CHLOROTHIAZIDE chlorothiazide TABLET;ORAL 084026-001 Sep 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharma Global CHLOROTHIAZIDE SODIUM chlorothiazide sodium INJECTABLE;INJECTION 091546-001 Jul 26, 2011 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz CHLOROTHIAZIDE chlorothiazide TABLET;ORAL 085485-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sagent Pharms CHLOROTHIAZIDE SODIUM chlorothiazide sodium INJECTABLE;INJECTION 202462-001 May 29, 2015 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa CHLOROTHIAZIDE SODIUM chlorothiazide sodium INJECTABLE;INJECTION 090896-001 Oct 16, 2009 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Medtronic
QuintilesIMS
Novartis
Dow
Mallinckrodt
McKesson
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot